Clinical Trial Suggests Soliris Could be an Effective Treatment for Neuromyelitis Optica Spectrum Disorders
qimono / Pixabay

Clinical Trial Suggests Soliris Could be an Effective Treatment for Neuromyelitis Optica Spectrum Disorders

According to a story from BusinessWire, the drug developer Alexion Pharmaceuticals, Inc., recently announced positive results for its Phase 3 trial testing Soliris as a therapy for neuromyelitis optica spectrum…

Continue Reading Clinical Trial Suggests Soliris Could be an Effective Treatment for Neuromyelitis Optica Spectrum Disorders
Researchers Discover More Information on the Genetic Basis of Neuromyelitis Optica
LionFive / Pixabay

Researchers Discover More Information on the Genetic Basis of Neuromyelitis Optica

According to a story from Newswise, a team of scientists and researchers have recently completed research that managed to reveal the genetic nature of the unusual rare disease neuromyelitis optica.…

Continue Reading Researchers Discover More Information on the Genetic Basis of Neuromyelitis Optica
A Widely Popular Allergy Medication Could Prevent Relapse in Neuromyelitis Optica
source: pixabay.com

A Widely Popular Allergy Medication Could Prevent Relapse in Neuromyelitis Optica

According to an article from brightsurf.com, a commonly used allergy medication called cetirizine (commonly marketed under the name Zyrtec) was able to prevent relapse in patients with neuromyelitis optica in…

Continue Reading A Widely Popular Allergy Medication Could Prevent Relapse in Neuromyelitis Optica